BioLife Solutions Inc. (BLFS)
$37.00
$-0.22
(-0.59%)
As on 26-Aug-2026 16:00EDT
Market cap
$1,814 Mln
Revenue (TTM)
$103 Mln
P/E Ratio
37.1
P/B Ratio
4.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.1 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
336.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$1
-
Face value
--
-
Shares outstanding
48,906,704
10 Years Aggregate
CFO
$-27.61 Mln
EBITDA
$-107.03 Mln
Net Profit
$-214.44 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BioLife Solutions (BLFS)
| 53.0 | 23.4 | 54.5 | 44.2 | 50.2 | -7.8 | 34.9 |
|
BSE Sensex*
| -8.8 | 1.6 | 1.6 | -4.4 | 6.0 | 6.7 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
BioLife Solutions (BLFS)
| -6.9 | 59.1 | -10.7 | -51.2 | -6.6 | 146.5 | 34.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
BioLife Solutions (BLFS)
|
37.0 | 1,814.4 | 102.8 | 50.5 | 6.0 | 12.7 | 37.1 | 4.3 |
| 64.3 | 8,484.6 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.1 | |
| 14.5 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.1 | 9,074.5 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 180.6 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.8 | 6,525.3 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24 | 5.0 | |
| 90.5 | 5,420.5 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 323.1 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 180.3 | 10,222.2 | 785.1 | 41.5 | 9.9 | 2 | 251.6 | 4.8 |
Shareholding Pattern
View DetailsAbout BioLife Solutions (BLFS)
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used... in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington. Read more
-
CEO & Chairman
Mr. Roderick de Greef
-
CEO & Chairman
Mr. Roderick de Greef
-
Headquarters
Bothell, WA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for BioLife Solutions (BLFS)
What is the current share price of BioLife Solutions Inc (BLFS) Today?
The share price of BioLife Solutions Inc (BLFS) is $37.00 (NASDAQ) as of 26-Aug-2026 16:00 EDT. BioLife Solutions Inc (BLFS) has given a return of 50.2% in the last 3 years.
What is the current PB & PE ratio of BioLife Solutions Inc (BLFS)?
The P/E ratio of BioLife Solutions Inc (BLFS) is 37.10 times as on 21-Aug-2026, a 17 discount to its peers’ median range of 44.46 times.
The P/B ratio of BioLife Solutions Inc (BLFS) is 4.30 times as on 21-Aug-2026, a 12 premium to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-96.97 |
3.16 |
2024 |
-61.78 |
3.57 |
2023 |
-10.96 |
2.16 |
2022 |
-5.57 |
2.14 |
2021 |
-174.36 |
3.25 |
What is the 52 Week High and Low of BioLife Solutions Inc (BLFS)?
The 52-week high and low of BioLife Solutions Inc (BLFS) are Rs 38.10 and Rs 17.86 as of 27-Aug-2026.
What is the market cap of BioLife Solutions Inc (BLFS)?
BioLife Solutions Inc (BLFS) has a market capitalisation of $ 1,814 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in BioLife Solutions Inc (BLFS)?
Before investing in BioLife Solutions Inc (BLFS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.